XML 41 R19.htm IDEA: XBRL DOCUMENT v3.22.2
Note 4 - Intangible Assets (Tables)
3 Months Ended
Jun. 30, 2022
Intangible Assets, Net (Excluding Goodwill) [Abstract]  
In Process Research and Development

Intangible assets of $69,810 relate to the value of IPR&D, related to Grace’s therapeutic pipeline, consisting of three unique clinical stage programs/assets supported by intellectual property, the value of which has been attributed as follows:

 

 

 

$

 

Intangible assets – in-process research and development

 

 

 

GTX-104

 

 

27,595

 

GTX-102

 

 

31,908

 

GTX-101

 

 

10,307

 

Total

 

 

69,810